Local excision for middle-low rectal cancer after neoadjuvant chemoradiation: A retrospective study from a single tertiary center

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

678

Figures (1-3)

128

Tables (1-4)

109

Sum=947

Publishing Process of This Article

Item

Count

Browse

Download

Sum=118

Dec 15, 2024 (publication date) through Feb 18, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4614-4624
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4614

Table 3 Patients with perioperative complications

Gender	Age	Neoadjuvant	Interval from NCRT to local excision (week)	Type of complications	Clavien-Dindo grades
Male	74	NCRT	69	Bleeding	II
Male	68	NCRT	18	Bleeding	I
Female	59	NCRT	11	Perineal pain	II
Female	71	NCRT	11	Perineal pain	II
Male	40	NCRT + CapOx	24	Perineal pain + stricture	II
Male	56	NCRT + CapOx	59	Pain + fecal incontinence	II
Female	66	NCRT + CapOx	32	Bleeding + pain	II

NCRT: Neoadjuvant chemoradiotherapy; CapOx: Capecitabine + oxaliplatin.

Citation: Chen N, Li CL, Wang L, Yao YF, Peng YF, Zhan TC, Zhao J, Wu AW. Local excision for middle-low rectal cancer after neoadjuvant chemoradiation: A retrospective study from a single tertiary center. World J Gastrointest Oncol 2024; 16(12): 4614-4624
URL: https://www.wjgnet.com/1948-5204/full/v16/i12/4614.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i12.4614